PASS Coalition applauds introduction of the Sunscreen Innovation Act
WASHINGTON — Legislation introduced to unclog the backlog of sunscreen ingredients and streamline the review process for faster public access has garnered the accolades of the Public Access to SunScreen Coalition.
"The Public Access to SunScreen Coalition applauds Senators Jack Reed, D-R.I., and Johnny Isakson, R-Ga., and Congressmen Ed Whitfield, R-Ky., and John Dingell, D-Mich., for their leadership in introducing the bipartisan, bicameral Sunscreen Innovation Act;" stated Wendy Selig, president and CEO of the Melanoma Research Alliance, an active member of the coalition. "This legislation is a responsible way to alleviate the current 12 year backlog of sunscreen ingredients, and streamline the review process so the public can gain access to the most effective and innovative sunscreen products."
The last OTC sunscreen ingredient to be approved was in the 1990s. Since that time, eight new sunscreen applications have been filed and are still awaiting review. New sunscreen technologies currently awaiting approval in the United States have been widely available in Europe, Asia, and Central and South America, in some cases for more than 15 years.
"Skin cancer is the most common form of cancer in the United States. Fortunately, it can be prevented through regular and appropriate use of sunscreens. This much needed and long overdue legislation is a key step for the approval of critical and innovative ingredients to be used in future sunscreens," stated Steven Wang, board-certified dermatologist at Memorial Sloan Kettering Cancer Center and member of the PASS Coalition. "The FDA has approved several new drugs for the treatment of melanoma in the recent years, and these drugs have made a profound impact on the lives of many patients with advanced disease. Now, it is time for the FDA to focus on prevention of skin cancers and approve the sunscreen ingredients that can better protect the public from harmful ultraviolet rays."
“In the U.S., one person dies every hour from melanoma and the numbers of skin cancer cases has risen dramatically. As we continue to educate the public about ways to reduce their risk for this deadly disease, it is imperative for Americans to have access to the most innovative and effective sunscreen products available,” added Selig.
"The creation of a predictable, transparent and timely review process for sunscreen ingredients addresses a growing public concern, and opens the door for further innovation," said Al Pearce, senior marketing manager personal care at BASF Corp., and member of the PASS Coalition. "The PASS Coalition strongly encourages swift legislative action in both the House and the Senate to see the Sunscreen Innovation Act become law."
The PASS Coalition is a multi-stakeholder coalition of public health organizations, dermatologists, sunscreen ingredient companies, and concerned citizens who will work collaboratively with the Food and Drug Administration, the White House and Congress to establish a timely and transparent framework for approval of the next generation of UV active filters for OTC sunscreens.
The Natural Dentist launches Spanish-language site
MADISON, N.J. — The Natural Dentist, a line of natural oral care products that contain a therapeutic amount of purified aloe vera, has launched a Spanish language web site.
The site is designed to introduce aloe vera as an agent for treating oral care issues.
"We’ve noticed a growing demand for our products, as well as information regarding bleeding gums, from the Spanish-speaking market," stated Kelly Kaplan, president of Revive Personal Products Company and distributer of the Natural Dentist. "The Aloe vera plant has long been used as an herbal remedy in Latino households and medicine, and its healing benefits are only recently becoming widespread and publicized. As the leading ingredient in our mouth rinse, we feel like our products are a natural fit for this growing demographic that is disproportionally affected by oral care issues."
According to the Hispanic Dental Association, Latinos are the fastest growing minority group and also the largest in the country, yet are more likely to lack access to dental care. A report in the Journal of the American Dental Association in September 2005 stated that the percentage of untreated oral disease for Hispanics (40%) and non-Hispanic blacks (48%) was nearly double that for non-Hispanic whites (24%).
The Natural Dentist Healthy Gums Mouth Rinse is available at retailers including Wal-Mart, Walgreens, Rite Aid and Whole Foods.
Ulta Beauty sees ‘excellent top line growth’ in Q4
BOLINGBROOK, Ill. — Beauty retailer Ulta Beauty posted double-digit sales gains for the fourth-quarter and a 9.5% boost in net income.
“Ulta Beauty achieved excellent top line growth in the fourth quarter,” stated Mary Dillon, CEO of Ulta Beauty. “We delivered earnings growth consistent with our expectations and made significant progress with our key growth strategies. I am very proud of the team’s accomplishments during 2013, including the completion of the most ambitious store opening program in our company’s history; the addition of 25 significant new brands contributing to 7.9% annual comparable store sales growth; exciting growth in our loyalty program, now 13 million members strong; and rapid growth in Ulta.com, driven by major steps forward in our e-commerce platform and fulfillment capabilities.”
Net sales for the quarter ended Feb. 1 rose 14.4% to $868.1 million. Excluding the sales of the 53rd week of fiscal 2012, sales rose 23.3%. Same-store sales rose 9.2% during the quarter. E-commerce comparable sales grew 82.5%.
Net income for the quarter rose 9.5% to $70.7 million, or $1.09 per diluted share, compared with $64.5 million, or $1 per diluted share, in the year-ago period.
For the fiscal year, sales rose 20.3% to $2.67 billion. Excluding sales for the 53rd week in fiscal 2012, sales rose 23.3%. Same-store sales for the year rose 7.9%. E-commerce comparable sales grew 76.6%.
Net income for the year rose 17.6% to $202.8 million, or $3.15 per diluted share, compared with $172.5 million, or $2.68 per diluted share, in the year-ago period.